Home » World » CDC Vaccine Advisers Unanimously Vote To Recommend Moderna Covid-19 Vaccine For People Ages 6 Through 17

CDC Vaccine Advisers Unanimously Vote To Recommend Moderna Covid-19 Vaccine For People Ages 6 Through 17

CDC Vaccine Advisers Unanimously Vote To Recommend Moderna Covid-19 Vaccine For People Ages 6 Through 17

The vaccine received emergency use authorization from the US Food and Drug Administration last week.

All 15 voting members of the CDC’s Advisory Committee on Immunization Practices (ACIP) voted yes on the statements:

“A two-dose Moderna COVID-19 vaccine (50mcg) is recommended for children ages 6 — 11 years, under the EUA issued by the FDA.”

“A two-dose Moderna COVID-19 vaccine (100mcg) is recommended for adolescents ages 12 — 17 years, under the EUA issued by the FDA.”

The CDC’s Advisory Committee on Immunization Practices endorsed the vaccine after hearing details about Moderna’s application to the FDA and the latest safety data.

“There is a risk of myocarditis/pericarditis after both messenger RNA Covid-19 vaccines, most cases have prompt improvement in symptoms. A follow up survey suggests most fully recovered from myocarditis,” said Dr. Helen Keipp Talbot, an associate professor of medicine from Vanderbilt University during ACIP’s discussion of the vaccine Thursday. She added that myocarditis after vaccination has been generally mild compared to those who developed myocarditis after getting sick from Covid-19.

The CDC said that the risk of myocarditis “may be higher” with the Moderna vaccine than from vaccination from Pfizer, but there are limitations to what scientists know about the condition in this age group since the data is observational and limited.

See also  Education leader race features qualification questions in SC

Overall, the data presented from the company showed that most children got the vaccine without incident.

“In general, most adverse events reported after Covid vaccines are mild and transient events like injection site and systemic reactions,” said Dr. Tom Shimabukuro, the Deputy Director of the H1N1 Vaccine Task Force at the CDC. “We will continue to monitor the safety…

Read full article on worldnewsera.com